Cann Global Ltd
ASX:CGB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cann Global Ltd
Revenue
Cann Global Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cann Global Ltd
ASX:CGB
|
Revenue
AU$562.3k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
24%
|
CAGR 10-Years
5%
|
|
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Revenue
AU$1.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$413m
|
CAGR 3-Years
38%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$76.8m
|
CAGR 3-Years
69%
|
CAGR 5-Years
145%
|
CAGR 10-Years
44%
|
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vita Life Sciences Ltd
ASX:VLS
|
Revenue
AU$93.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
|
Cann Global Ltd
Glance View
Cann Global Ltd. engages in the mining exploration and evaluation. The company is headquartered in Sydney, New South Wales. The company went IPO on 2008-01-14. The Company’s divisions include Food, Hemp Cultivation, and Processing, Skincare, Medicine, and Mining division. The Food division is focused on the production and distribution of healthy and nutritious plant-based food products for discerning Australian and Asian consumers. Hemp Cultivation and Processing division includes hulling in Australia, and broad-acre industrial cannabidiol (CBD) hemp cultivation and processing in Asia where growing conditions are ideal. The Skincare division, which includes oil, serum, and a cream product all contain hemp seed oil as the primary active ingredient. The Medicine division is responsible for research into the medicinal uses of cannabis, including research into the benefits for those with auto-immune diseases. The Mining division holds bauxite assets in the South Johnstone project, Queensland (EPM 18463).
See Also
What is Cann Global Ltd's Revenue?
Revenue
562.3k
AUD
Based on the financial report for Jun 30, 2022, Cann Global Ltd's Revenue amounts to 562.3k AUD.
What is Cann Global Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was -62%. The average annual Revenue growth rates for Cann Global Ltd have been -2% over the past three years , 24% over the past five years , and 5% over the past ten years .
